Aims Atrial fibrillatory cycle length (AFCL) is generally accepted as a surrogate marker for local refractoriness. In this study, a computer model and clinical data on human subjects undergoing catheter ablation for paroxysmal and persistent AF were used to determine the clinical potential of AFCL.
Alfio Quarteroni, Andrea Manzoni, Luca Dede', Stefano Pagani
Nikolaos Stergiopoulos, Patrick Segers
Olaf Blanke, Andrea Serino, Nathan Quentin Faivre, Marco Solcà, Pavo Orepic, Tommaso Enrico Bertoni, Gaurav Sharma